Clinical genetics

  • Bioarray pioneered the use of microarray CGH and NGS in the clinical area
  • Bioarray uses own bioinformatic pipelines to make the most of the analysis and interpretation of raw data
  • Bioarray expertise in the research field adds extra insight for clinical diagnosis
Why taking a test?
Genetic tests are aimed at obtaining the molecular confirmation of a clinically suspected genetic disease. In turn, this can help determine a person's chance of passing on such genetic condition.
How does it work?
Just use our online ordering process to select the suitable test and fill in the relevant data. Forms, shipping labels and instruction will be generated for the collection of the sample (blood, saliva, buccal swab) using our own courier system.

Range of NGS tests, based on Clinical and Whole Exome Sequencing.
Choice of target genes number and different turnaround times, according to diagnostic requirements.


Range of tests using microarray CGH, for the diagnosis of cromosomal alterations.
Indicated for mental/development retardation, congenital malformation, autism spectrum disorder or clinical picture of a specific cromosomal syndrome.

General Oncology

Non invasive, hight sensitivity test for detection of cell-free circulating tumor DNA (ctDNA) in the patient's bloodstream.
It allows to adapt the treatment and monitor the tumor's progression. Panels for breast, lung and colon cancer.

NGS panels

NGS sequencing panels for molecular confirmation and typing of epilepsy.
Bioarray's most comprehensive panel targets 543 genes linked to epilepsy.

Clinical Genetic Counseling

The fast development of diagnostic techniques applied to the study of genetically based human pathologies over the past decade has made it possible to reliably study these pathologies...

NGS Carrier Screening Panel

The carrier screening panel is a genetic test that simultaneously analysis mutations in 298 genes which cause recessive inherited pathologies.